Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study
出版年份 2021 全文链接
标题
Cardiovascular Risk Associated With Ibrutinib Use in Chronic Lymphocytic Leukemia: A Population-Based Cohort Study
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages JCO.21.00693
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2021-09-01
DOI
10.1200/jco.21.00693
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.
- (2021) John C. Byrd et al. JOURNAL OF CLINICAL ONCOLOGY
- Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase 1b/2 PCYC-1102 Study
- (2020) John C. Byrd et al. CLINICAL CANCER RESEARCH
- Ibrutinib-Mediated Atrial Fibrillation Due to Inhibition of CSK
- (2020) Ling Xiao et al. CIRCULATION
- Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis
- (2019) Daniel Caldeira et al. PLoS One
- Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium
- (2019) Le Jiang et al. HEART RHYTHM
- Ibrutinib related bleeding complications in elderly patients with B cell malignancies
- (2019) Roberto Castelli et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
- (2019) Tait D. Shanafelt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
- (2019) Ethan B. Ludmir et al. JAMA Oncology
- Hypertension and incident cardiovascular events following ibrutinib initiation
- (2019) Tyler Dickerson et al. BLOOD
- Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients
- (2019) Maryam Sarraf Yazdy et al. BLOOD
- Cardiovascular Toxicities Associated With Ibrutinib
- (2019) Joe-Elie Salem et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Identifying diabetes cases from administrative data: a population-based validation study
- (2018) Lorraine L. Lipscombe et al. BMC HEALTH SERVICES RESEARCH
- Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study
- (2018) Thomas Gilbert et al. LANCET
- Risk of Major Bleeding with Ibrutinib
- (2018) Joseph Mock et al. Clinical Lymphoma Myeloma & Leukemia
- Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies
- (2018) Avirup Guha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
- (2018) Lauren Lapointe-Shaw et al. PLoS One
- Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis
- (2018) Jennifer R. Brown et al. BRITISH JOURNAL OF HAEMATOLOGY
- Propensity-score matching with competing risks in survival analysis
- (2018) Peter C. Austin et al. STATISTICS IN MEDICINE
- Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
- (2017) Jennifer R. Brown et al. HAEMATOLOGICA
- Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies
- (2017) J. J. Shatzel et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Practical recommendations for the choice of anticoagulants in the management of patients with atrial fibrillation on ibrutinib
- (2017) Khai Li Chai et al. LEUKEMIA & LYMPHOMA
- Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
- (2017) Jennifer R. Brown et al. HAEMATOLOGICA
- The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis
- (2016) Darryl P. Leong et al. BLOOD
- Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders
- (2016) Stephen P. Mulligan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Identifying Patients With Atrial Fibrillation in Administrative Data
- (2016) Karen Tu et al. CANADIAN JOURNAL OF CARDIOLOGY
- Accuracy of Administrative Data for the Coding of Acute Stroke and TIAs
- (2016) Ruth Hall et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Identification of Physician-Diagnosed Alzheimer’s Disease and Related Dementias in Population-Based Administrative Data: A Validation Study Using Family Physicians’ Electronic Medical Records
- (2016) R. Liisa Jaakkimainen et al. JOURNAL OF ALZHEIMERS DISEASE
- Three-year follow-up of treatment-naive and previously treated patients with CLL and SLL receiving single-agent ibrutinib
- (2015) J. C. Byrd et al. BLOOD
- The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): Using Big Data to Measure and Improve Cardiovascular Health and Healthcare Services
- (2015) J. V. Tu et al.
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
- (2015) Renate B Schnabel et al. LANCET
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): Using Big Data to Measure and Improve Cardiovascular Health and Healthcare Services
- (2015) J. V. Tu et al. Circulation-Cardiovascular Quality and Outcomes
- Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling
- (2014) J. R. McMullen et al. BLOOD
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Validity of Administrative Data for Identifying Patients Who Have Had a Stroke or Transient Ischemic Attack Using EMRALD as a Reference Standard
- (2013) Karen Tu et al. CANADIAN JOURNAL OF CARDIOLOGY
- Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes
- (2013) Jamie L Fleet et al. BMC Nephrology
- Rates of hemorrhage during warfarin therapy for atrial fibrillation
- (2012) T. Gomes et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Validation of physician billing and hospitalization data to identify patients with ischemic heart disease using data from the Electronic Medical Record Administrative data Linked Database (EMRALD
- (2011) Karen Tu et al. CANADIAN JOURNAL OF CARDIOLOGY
- Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study
- (2011) Andrea S Gershon et al. LANCET
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
- (2010) Peter C. Austin PHARMACEUTICAL STATISTICS
- Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction
- (2009) Douglas S. Lee et al. CIRCULATION
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
- (2009) Peter C. Austin STATISTICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More